Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1

BACKGROUND: Metaplastic breast carcinoma encompasses a heterogeneous group of tumours with differentiation into squamous and/or spindle, chondroid, osseous or rhabdoid mesenchymal-looking elements. Emerging immunotherapies targeting Programmed Death Ligand 1 (PD-L1) and immune-suppressing T cells (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalaw, Emarene, Lim, Malcolm, Kutasovic, Jamie R., Sokolova, Anna, Taege, Lucinda, Johnstone, Kate, Bennett, James, Saunus, Jodi M., Niland, Colleen, Ferguson, Kaltin, Gresshoff, Irma, Bettington, Mark, Pathmanathan, Nirmala, Tse, Gary M., Papadimos, David, Pathmanathan, Rajadurai, Harris, Gavin, Yamaguchi, Rin, Tan, Puay Hoon, Fox, Stephen, O’Toole, Sandra A., Simpson, Peter T., Lakhani, Sunil R., McCart Reed, Amy E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686342/
https://www.ncbi.nlm.nih.gov/pubmed/32939056
http://dx.doi.org/10.1038/s41416-020-01065-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686342/
https://www.ncbi.nlm.nih.gov/pubmed/32939056
http://dx.doi.org/10.1038/s41416-020-01065-3

Ejemplares similares